Biomanufacturing (BioMAN) Research Program
The mission of the MIT CBI BioMANufacturing Research Program is to develop innovative tools and technologies that reduce the cost of manufacturing processes and improve our ability to deliver safe high quality biopharmaceutical products.
To address emerging biomanufacturing needs, BioMAN activities are focused on:
- New science and engineering advances for the safe and consistent production of biologics.
- Technologies that shorten the time to develop a biotherapeutic and decrease associated costs.
- Management of risk, such as adventitious agent contamination, associated with changes in the biopharmaceutical landscape.
- Low-cost global delivery of biotherapeutics.
To meet our mission, BioMAN fosters a collaborative research environment that brings together thought leaders from industry, the government/FDA and academia.
For more information about BioMAN, please contact our Program Director:
Dr. Stacy L. Springs
ssprings@mit.edu
Phone: 617-253-3084